Optimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of publi...

por Li, Cunfu, Xiang, Aizhai, Chen, Xianzhi, Yin, Kai, Lu, Jinsong, Yin, Wenjin
Publicado en Onco Targets Ther (2017)

PCOLCE Is Potent Prognostic Biomarker and Associates With Immune Infiltration in Gastric Cancer

por Xiang, Aizhai, Lin, Xia, Xu, Lvping, Chen, Honggang, Guo, Jufeng, Zhou, Fang
Publicado en Front Mol Biosci (2020)